Skip to main content
. 2013 May 27;8(1):11–16. doi: 10.3892/mmr.2013.1492

Figure 1.

Figure 1

Cf-GP reduces the viability of AGS human gastric cancer cells. AGS cells were treated with 0, 5, 10 or 20 μg/ml Cf-GP for 24 h. Cell viability was measured using the MTS assay. Data are presented as the means ± SD; P<0.05 by ANOVA. Values with different letters are significantly different according to Duncan's multiple range test. Cf-GP, Capsosiphon fulvescens glycoprotein. MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfonyl)-2H-tetrazolium.